Evidence map›Paper›PMID 17145771›Full record

ArticleMolecular and cellular biology2007

Extracellular signal-regulated protein kinase 2 is required for efficient generation of B cells bearing antigen-specific immunoglobulin G.

Hideki Sanjo, Masaki Hikida, Yuichi Aiba, Yoshiko Mori, Naoya Hatano, Masato Ogata, Tomohiro Kurosaki

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Mitogen-activated protein kinase signalling and ERK1/2 bistability in asthma.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2011
    Review
  6. Article
  7. Raf-independent, PP2A-dependent MEK activation in response to ERK silencing.Biochemical and biophysical research communications · 2009
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hideki SanjoLaboratory for Lymphocyte Differentiation, RIKEN Research Center for Allergy and Immunology, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.
Masaki Hikida
Yuichi Aiba
Yoshiko Mori
Naoya Hatano
Masato Ogata
Tomohiro Kurosaki
RIKEN Center for Integrative Medical Sciences · JPOsaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Activation of extracellular signal-regulated protein kinase (ERK) has been implicated in proliferation as well as differentiation in a wide variety of cell types. Using B-cell-specific gene-targeted mice, we report here that in T-cell-dependent immune responses, ERK2 is required to generate efficient immunoglobulin G (IgG) production. In its absence, the proportion of antigen-specific surface IgG1-bearing cells and the subsequent number of IgG1 antibody-secreting cells were decreased, despite apparently unimpaired class switch recombination. Notably, this defect was countered by overexpression of the antiapoptotic factor Bcl-2. Together, our results suggest that ERK2 plays a key role in efficient generation of antigen-specific IgG-bearing B cells by promoting their survival.

Indexed as

AnimalsAntibody FormationAntibody SpecificityAntigensAntigens, CD19B-LymphocytesBone Marrow CellsCell CountCell ProliferationGene ExpressionImmunoglobulin Class SwitchingImmunoglobulin GMiceMitogen-Activated Protein Kinase 1Proto-Oncogene Proteins c-bcl-2SpleenAntigensAntigens, CD19Immunoglobulin GMitogen-Activated Protein Kinase 1Proto-Oncogene Proteins c-bcl-2

Identifiers

PMID17145771
PMCPMC1800707
OpenAlexW2145410764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.